January 1, 2024 · Form 4 insider transaction
Klopfenstein John D bought 1,592 shares of FRPH at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
The Reporting Person was awarded shares of restricted stock pursuant to the Issuer's Equity Incentive Plan. The shares are subject to performance-based vesting criteria for the two-year period ending December 31, 2025. If the performance-based criteria are achieved, 25% of the shares will vest upon the Compensation Committee's determination (in March 2026) that such criteria have been achieved, and 25% will vest on December 31st of each of 2026, 2027, and 2028, subject to the Reporting Person's continued employment.